Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Expression of fully functional tetrameric human hemoglobin in Escherichia coliS J Hoffman, D L Looker, J M Roehrich, et al.International Nursing Review|June 3, 2020
Nursing practice and global refugee migration: initial impressions from an Intergovernmental-Academic PartnershipV Bampoh, M Thongkhamkitcharoen, S Dicker, et al.Journal of Medicinal Chemistry|December 22, 2000
Synthesis and structure-activity relationships of chiral allosteric modifiers of hemoglobinM Phelps Grella, R Danso-Danquah, M K Safo, et al.The Journal of Pharmacology and Experimental Therapeutics|November 24, 1999
Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritisA M Badger, S M Blake, R A Dodds, et al.Arthritis and Rheumatism|February 24, 2001
Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritisA M Badger, S Blake, R Kapadia, et al.Arthritis and Rheumatism|January 22, 2000
Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritisA M Badger, D E Griswold, R Kapadia, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2001
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primateG B Stroup, M W Lark, D F Veber, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 24, 2001
Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized ratM W Lark, G B Stroup, R A Dodds, et al.Bone|May 9, 2002
A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized ratMichael W Lark, G B Stroup, I E James, et al.Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis modelW H Miller, W E Bondinell, R D Cousins, et al.Pageof 3